Profile: Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ)
002294.SZ on Shenzhen Stock Exchange
18 Jan 2017
18 Jan 2017
Change (% chg)
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company engaged in the research, development, manufacture and sales of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company's medicines for cardiovascular diseases include clopidogrel bisulfate tablets, benazepril hydrochloride tablets and pamidronate disodium for injection. The Company's antibiotics include cefepime hydrochloride for injection, cefuroxime sodium for injection, cefoxitin sodium for injection and others. The Company's bulk drugs include cefepime hydrochloride, cefuroxime sodium, cefoxitin sodium and others. The Company distributes the products within domestic market.
Shenzhen Salubris Pharmaceuticals Co Ltd
F37, Main Building,Chegong Templ
Lvgem NEO Square,No.6009 Shennan
SHENZHEN GNG 518040
Company Web Links
- BRIEF-Shenzhen Salubris Pharmaceuticals plans JV, with partners
- BRIEF-Shenzhen Salubris Pharmaceuticals expects 2016 net profit to increase by 5 to 15 pct above I/B/E/S estimates
- BRIEF-Shenzhen Salubris Pharmaceuticals' Q3 net profit up 12.5 pct
- BRIEF-Shenzhen Salubris Pharmaceuticals unit to inject capital in biomedical tech firm
- BRIEF-Shenzhen Salubris Pharma's unit to acquire Salubris Biotherapeutics Inc in U.S.